209 related articles for article (PubMed ID: 18829559)
1. Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model.
Fred C; Törnqvist M; Granath F
Cancer Res; 2008 Oct; 68(19):8014-21. PubMed ID: 18829559
[TBL] [Abstract][Full Text] [Related]
2. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
3. Quantification of DNA and hemoglobin adducts of 3,4-epoxy-1,2-butanediol in rodents exposed to 3-butene-1,2-diol.
Powley MW; Li Y; Upton PB; Walker VE; Swenberg JA
Carcinogenesis; 2005 Sep; 26(9):1573-80. PubMed ID: 15888494
[TBL] [Abstract][Full Text] [Related]
4. The importance of 3,4-epoxy-1,2-butanediol and hydroxymethylvinyl ketone in 3-butene-1,2-diol associated mutagenicity.
Powley MW; Walker VE; Li Y; Upton PB; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):182-90. PubMed ID: 17349618
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.
Albertini RJ; Sram RJ; Vacek PM; Lynch J; Rossner P; Nicklas JA; McDonald JD; Boysen G; Georgieva N; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):63-77. PubMed ID: 16949064
[TBL] [Abstract][Full Text] [Related]
6. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene.
Booth ED; Kilgour JD; Watson WP
Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822
[TBL] [Abstract][Full Text] [Related]
7. Measurement of plasma or urinary metabolites and Hprt mutant frequencies following inhalation exposure of mice and rats to 3-butene-1,2-diol.
Walker DM; McDonald JD; Meng Q; Kracko DA; Bauer MJ; Seilkop SK; Walker EL; Henderson RF; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):191-206. PubMed ID: 17316587
[TBL] [Abstract][Full Text] [Related]
8. Quantitative investigation on the metabolism of 1,3-butadiene and of its oxidized metabolites in once-through perfused livers of mice and rats.
Filser JG; Bhowmik S; Faller TH; Hutzler C; Kessler W; Midpanon S; Pütz C; Schuster A; Semder B; Veereshwarayya V; Csanády GA
Toxicol Sci; 2010 Mar; 114(1):25-37. PubMed ID: 20007191
[TBL] [Abstract][Full Text] [Related]
9. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
Fred C; Grawé J; Törnqvist M
Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
[TBL] [Abstract][Full Text] [Related]
10. A review of the genetic and related effects of 1,3-butadiene in rodents and humans.
Jackson MA; Stack HF; Rice JM; Waters MD
Mutat Res; 2000 Oct; 463(3):181-213. PubMed ID: 11018742
[TBL] [Abstract][Full Text] [Related]
11. 1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment.
Kirman CR; Albertini RJ; Sweeney LM; Gargas ML
Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():1-11. PubMed ID: 20868266
[TBL] [Abstract][Full Text] [Related]
12. Differences in butadiene adduct formation between rats and mice not due to selective inhibition of CYP2E1 by butadiene metabolites.
Pianalto KM; Hartman JH; Boysen G; Miller GP
Toxicol Lett; 2013 Nov; 223(2):221-7. PubMed ID: 24021170
[TBL] [Abstract][Full Text] [Related]
13. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
14. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene.
Meng Q; Walker DM; McDonald JD; Henderson RF; Carter MM; Cook DL; McCash CL; Torres SM; Bauer MJ; Seilkop SK; Upton PB; Georgieva NI; Boysen G; Swenberg JA; Walker VE
Chem Biol Interact; 2007 Mar; 166(1-3):121-31. PubMed ID: 16945358
[TBL] [Abstract][Full Text] [Related]
15. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
16. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
17. Approach for cancer risk estimation of acrylamide in food on the basis of animal cancer tests and in vivo dosimetry.
Törnqvist M; Paulsson B; Vikström AC; Granath F
J Agric Food Chem; 2008 Aug; 56(15):6004-12. PubMed ID: 18624431
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA
Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907
[TBL] [Abstract][Full Text] [Related]
19. 1,3-Butadiene: III. Assessing carcinogenic modes of action.
Kirman CR; Albertini RA; Gargas ML
Crit Rev Toxicol; 2010 Oct; 40 Suppl 1():74-92. PubMed ID: 20868268
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace.
Bond JA; Recio L; Andjelkovich D
Carcinogenesis; 1995 Feb; 16(2):165-71. PubMed ID: 7859344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]